Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

Following in the footsteps of other pharmaceutical companies, Bristol Myers Squibb and Pfizer are offering Eliquis for cash-paying patients at a discount of 40% off the list price.

Pfizer acquired Seagen in 2023 for $43 billion, and shut down construction on a $350 million manufacturing facility the ...

Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC), but only as a combination therapy.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment analysis of PFE stock.

We think Pfizer’s top line will see growth in the low teens, driven by market share gains for Vyndaqel and Abrysvo.

In a move that might allow them to sell drugs directly to patients, some drugmakers are getting into the telehealth business.

Some drugmakers are getting into the telehealth business in a move that might allow them to sell drugs directly to patients.

Struggling with plunging demand for its Covid products, Pfizer Inc. has a new plan to reach potential customers: Using telehealth to sell drugs straight to patients.

Pfizer CEO Albert Bourla heralded the site launch in a post on LinkedIn, noting that PfizerForAll seeks to aid Americans “overwhelmed by the abundance of online health information.” Going forward, the ...